Atypical psychotropics not more dangerous than conventional antipsychotics, study finds

Share this article:
Atypical antipsychotic medications are no more dangerous than other conventional antipsychotics, antidepressants and benzodiazepines when it comes to treating nursing home residents, according to a new study. Although psychotropic drugs are commonly used to treat nursing home patients with dementia, these treatments are not approved by the Food and Drug Administration. The FDA has advised that both atypical and common antipsychotics are associated with an increased risk of death, and that certain atypical antipsychotics, such as risperidone, olanzapine and aripiprazole, are associated with an increased risk of stroke, according to researchers from Brigham and Women's Hospital in Boston.
http://www.brighamandwomens.org/
Share this article:
close

Next Article in Products

More in Products

ACO white paper geared toward post-acute providers

A new white paper focuses on what kinds of services accountable care organizations should provide in the post-acute spectrum.

Accutech Security releases wander management system

Accutech Security releases wander management system

Accutech Security has released its new ResidentGuard LS 2400 wander management system, which can be used in senior living settings.

Sharps Compliance Corp. and MedReturn, LLC launch MedSafe

Sharps Compliance Corp. and MedReturn, LLC launch MedSafe

The Sharps Compliance Corp. and MedReturn LLC have created MedSafe, a system set up to dispose of unwanted and expired medications, including controlled substances.